The reproducibility and reliability of ELISA assays used to detect autoantibodies that recognize cardiolipin or β2-glycoprotein I remain unacceptable, which can complicate the diagnosis of antiphospholipid syndrome. Now, much needed international consensus guidelines have been proposed for the development and use of these diagnostic tests, which should improve their performance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lakos, G. et al. International consensus guidelines on anticardiolipin and anti-β2 glycoprotein I testing: a report from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum. http://dx.doi.org/10.1002/art.33349.
Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295–306 (2006).
Pengo, V. et al. Update of the guidelines for lupus anticoagulant detection. J. Thromb. Haemost. 7, 1737–1740 (2009).
Jennings, I. et al. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br. J. Haematol. 119, 364–369 (2002).
Reber, G., Boehlen, F. & de Moerloose, P. Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream? Semin. Thromb. Hemost. 34, 340–346 (2008).
Macdonald P. M. & Seelig, J. Calcium binding to mixed cardiolipin–phosphatidylcholine bilayers as studied by deuterium nuclear magnetic resonance. Biochemistry 26, 6292–6298 (1987).
de Groot, P. G., Horbach, D. A., Simmelink, M. J., van Oort, E. & Derksen, R. H. Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant. Lupus 7 (Suppl. 2), S32–S36 (1998).
de Groot, P. G. & Meijers, J. C. β2-glycoprotein I: evolution, structure and function. J. Thromb. Haemost. 9, 1275–1284 (2011).
Ioannou, Y. et al. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I. Arthritis Rheum. 63, 2774–2782 (2011).
Pengo, V., Biasiolo, A., Bison, E., Chantarangkul, V. & Tripodi, A. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2-glycoprotein I activity. Thromb. Res. 120, 127–133 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
de Groot, P., Urbanus, R. Guidelines for antiphospholipid antibody detection. Nat Rev Rheumatol 8, 125–126 (2012). https://doi.org/10.1038/nrrheum.2011.188
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2011.188
